Dulaglutide
Trulicity (dulaglutide) is a protein pharmaceutical. Dulaglutide was first approved as Trulicity on 2014-09-18. It is used to treat type 2 diabetes mellitus in the USA. It has been approved in Europe to treat type 2 diabetes mellitus.
Trade Name | Trulicity |
---|---|
Common Name | Dulaglutide |
Indication | type 2 diabetes mellitus |
Drug Class | Peptides: GLP peptide analogs |
